IPCALAB — Ipca Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	37,732	46,487	54,200	58,298	62,443
Cost of Revenue
Gross Profit	22,788	27,090	33,861	34,487	35,130
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	32,435	39,354	41,224	47,714	55,448
Operating Profit	5,297	7,133	12,976	10,584	6,996
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,465	7,389	13,813	11,146	7,453
Provision for Income Taxes
Net Income After Taxes	4,422	6,036	11,411	8,898	4,919
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	4,448	6,063	11,400	8,841	4,713
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,448	6,063	11,400	8,841	4,713
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17.6	24.7	45.7	35.2	18.2
Dividends per Share